Valinomycin-induced cation transport in vesicles does not reflect the activity of K+ transport systems in Escherichia coli. 1986

K Altendorf, and W Epstein, and A Löhmann

Transport systems for K+ in Escherichia coli are not detectable in membrane vesicles, but vesicles will take up K+ (and Rb+) in the presence of valinomycin. It is generally believed that valinomycin acts as a lipid-soluble cation carrier and that it does not interact with or activate cation transport systems. This view is challenged by Bhattacharyya et al. (Proc. Natl. Acad. Sci. USA 68:1448-1492, 1971), who reported reduced uptake in vesicles from E. coli mutants with K+ transport defects. We reexamined this question with some of the same mutants and were unable to confirm a correlation of valinomycin-induced vesicle transport with transport properties in intact cells. We found great variability in transport activity of vesicles from these E. coli K-12 strains and believe such variability as well as possible contamination with intact cells accounts for the earlier report. Our data do not support the idea that valinomycin-mediated transport in vesicles is related to physiological K+ transport systems.

UI MeSH Term Description Entries
D007476 Ionophores Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes. Ionophore
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D012413 Rubidium An element that is an alkali metal. It has an atomic symbol Rb, atomic number 37, and atomic weight 85.47. It is used as a chemical reagent and in the manufacture of photoelectric cells.
D014634 Valinomycin A cyclododecadepsipeptide ionophore antibiotic produced by Streptomyces fulvissimus and related to the enniatins. It is composed of 3 moles each of L-valine, D-alpha-hydroxyisovaleric acid, D-valine, and L-lactic acid linked alternately to form a 36-membered ring. (From Merck Index, 11th ed) Valinomycin is a potassium selective ionophore and is commonly used as a tool in biochemical studies.

Related Publications

K Altendorf, and W Epstein, and A Löhmann
September 1978, The Journal of general physiology,
K Altendorf, and W Epstein, and A Löhmann
January 1966, The Journal of general physiology,
K Altendorf, and W Epstein, and A Löhmann
July 1971, Proceedings of the National Academy of Sciences of the United States of America,
K Altendorf, and W Epstein, and A Löhmann
November 1963, The Journal of general physiology,
K Altendorf, and W Epstein, and A Löhmann
November 1968, The Journal of biological chemistry,
K Altendorf, and W Epstein, and A Löhmann
November 1981, Journal of bacteriology,
K Altendorf, and W Epstein, and A Löhmann
December 1973, Journal of bacteriology,
K Altendorf, and W Epstein, and A Löhmann
August 1971, Comparative biochemistry and physiology. B, Comparative biochemistry,
K Altendorf, and W Epstein, and A Löhmann
November 1961, The Journal of general physiology,
K Altendorf, and W Epstein, and A Löhmann
August 1975, FEBS letters,
Copied contents to your clipboard!